STAGE 0 BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE 0 BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE 0 BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE 0 BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Keytruda aims to stop Triple-Negative breast cancer return in High-Risk patients
Disease control OngoingThis phase III trial tests whether adding pembrolizumab (Keytruda) after standard chemotherapy can help prevent triple-negative breast cancer from coming back. Over 1,100 patients with residual cancer after chemo are randomly assigned to receive pembrolizumab or placebo. The stud…
Matched conditions: STAGE 0 BREAST CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 08:00 UTC
-
Proton beam radiation aims to spare healthy tissue in breast cancer treatment
Disease control OngoingThis phase II trial is testing a type of radiation called proton beam therapy for women with early-stage breast cancer (stage 0 to II). The goal is to see if this targeted approach can kill cancer cells while causing less damage to normal tissue, leading to fewer side effects and…
Matched conditions: STAGE 0 BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New radiation approach aims to cut treatment time and side effects for breast cancer
Disease control TerminatedThis study tests a shorter, more focused radiation treatment (hypofractionated partial breast irradiation) for women with early-stage breast cancer. The goal is to see if targeting only the tumor site can reduce side effects and improve cosmetic outcomes compared to standard whol…
Matched conditions: STAGE 0 BREAST CANCER AJCC V6 AND V7
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC